circSMAD4 regulates the progression of experimental colitis via the miR-135a-5p/JAK2 signalling axis .
circSMAD4 Promotes Experimental Colitis and Impairs Intestinal Barrier Functions by Targeting Janus Kinase 2 Through Sponging miR-135a-5p.